UK markets open in 3 hours 42 minutes
  • NIKKEI 225

    +578.59 (+2.01%)

    +14.79 (+0.05%)

    +0.06 (+0.09%)

    +4.00 (+0.22%)
  • DOW

    +97.34 (+0.29%)

    +1,115.33 (+2.80%)
  • CMC Crypto 200

    +58.13 (+4.14%)
  • ^IXIC

    -51.08 (-0.37%)
  • ^FTAS

    +54.76 (+1.38%)

Global Cardiac Monitoring & Cardiac Rhythm Management Market (2020 to 2025) - Featuring Abbott Laboratories, ACS Diagnostics and BioTelemetry Among Others -

·4-min read

The "Global Cardiac Monitoring & Cardiac Rhythm Management Market (2020-2025) by Product, Type, End user, Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to's offering.

The Global Cardiac Monitoring & Cardiac Rhythm Management Market is estimated to be USD 21.6 Bn in 2020 and is expected to reach USD 27.31 Bn by 2025, growing at a CAGR of 4.8%.

The increasing instance of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market. The implantable device technology uses complementary metal-oxide-semiconductor (CMOS) which are vulnerable to damage by the therapeutic doses of radiation, but it can vary according to the type of device in use. This factor is one of the major factors that limits the scope of using cardiac rhythm management devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. On the other hand, the high cost of these devices with limited insurance coverage is limiting the growth of the market.

Companies Mentioned

  • Abbott Laboratories

  • Abiomed, Inc.

  • ACS Diagnostics

  • Alivecor, Inc.

  • Amiitalia

  • Applied Cardiac System

  • Asahi Kasei Corporation

  • Berlin Heart GmbH

  • Bexen Cardio

  • BioTelemetry

  • Biotronik SE & Co. KG

  • Boston Scientific Corporation

  • BPL Medical Technologies

  • BTL

  • Cardiac Science Corporation

  • Cardionet Inc.

  • General Electric Company (GE)

  • Hill-Rom Holdings, Inc.

  • Jarvik Heart, Inc.

  • Koninklijke Philips N.V.

  • Lepu Medical Technology

  • LivaNova PLC

  • Medtronic plc

  • MeTrax GmbH

  • MicroPort Scientific Corporation

  • Mortara Instrument, Inc.

  • Narang Medical Limited

  • Nihon Kohden Corporation

  • OSI Systems, Inc.


  • Philips Healthcare

  • Progetti Srl

  • ReliantHeart Inc.


  • Shenzhen Mindray Bio-Medical Electronics

  • Shree Pacetronix

  • Siemens AG

  • Spacelabs healthcare

  • St. Jude Medical, Inc.

  • Stryker Corporation

  • Zoll Medical Corporation

Competitive Quadrant

The report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Cardiac Monitoring & Cardiac Rhythm Management Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.

  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.

  • The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.

  • The report also contains the competitive analysis using IGR Competitive Quadrant, the analyst's proprietary competitive positioning tool.

Key Topics Covered:

1 Report Description

2 Research Methodology

2.1 Research Process

2.2 Data Collection and Validation

2.2.1 Secondary Research

2.2.2 Primary Research

2.3 Market Size Estimation

2.4 Assumptions of the Study

2.5 Limitations of the Study

3 Executive Summary

4 Market Overview

4.1 Introduction

4.2 Market Dynamics

4.2.1 Drivers

4.2.2 Rising prevalence of cardiovascular disease

4.2.3 Availability of reimbursement for CM & CRM devices

4.2.4 Launch of innovative products by market players

4.2.5 Increasing investments, funds, and grants for research on CM & CRM devices

4.2.6 Growing preference for wearable cardiac devices

4.3 Restraints

4.3.1 Frequent product recalls

4.4 Opportunities

4.4.1 Measures to reduce infections caused due to CIEDs

4.5 Challenges

4.5.1 Risk of associated cyber security vulnerabilities

4.5.2 Stringent regulatory requirements delaying the approval of cardiac devices

4.5.3 Dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices

4.6 Trends

5 Market Analysis

5.1 Porter's Five Forces Analysis

5.2 Impact of COVID-19

5.3 Ansoff Matrix Analysis

6 Global Cardiac Monitoring & Cardiac Rhythm Management Market, By Product

6.1 Introduction

6.2 ECG Devices

6.3 Implantable Loop Recorders

6.4 Mobile Cardiac Telemetry Devices

6.5 Cardiac Output Monitoring Devices

6.6 Event Monitors

6.7 Smart ECG Monitors

7 Global Cardiac Monitoring & Cardiac Rhythm Management Market, By Type

7.1 Introduction

7.2 Defibrillators

7.3 Pacemakers

7.4 Others

8 Global Cardiac Monitoring & Cardiac Rhythm Management Market, By End User

8.1 Introduction

8.2 Hospitals

8.3 Clinics, Cardiac Centers, and Ambulatory Surgery Centers

8.4 Other End Users

9 Global Cardiac Monitoring & Cardiac Rhythm Management Market, By Geography

9.1 Introduction

9.2 North America

9.3 South America

9.4 Europe

9.5 Asia-Pacific

9.6 Rest of the World

10 Competitive Landscape

11 Company Profiles

12 Appendix

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900